Study Using an Investigational Product for the Treatment of Acne Vulgaris

What we are studying

To assess the safety and effectiveness of an investigational gel versus placebo control (no active medicine) applied topically once daily for 12 weeks in patients with acne vulgaris.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 12+

Eligibility Criteria

  • Minimum of 20 but not more than 50 papules and pustules on the face
  • Minimum of 30 but not more than 100 whiteheads or blackheads on the face
  • Cannot have one or more nodule(s) or cyst(s) above the jawline or severe cystic acne
  • Cannot be pregnant; nursing or planning a pregnancy during the study

What is involved

  • Up to 16 weeks for study participation with 6-7 visits to the study center
  • Urine pregnancy test
  • Physical Examination
  • Questionnaire during some visits

Contact Information

Study Coordinator
Dermatology Clinical Studies
Email
dermadvertising@wakehealth.edu
Phone
336-716-3775

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.